Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail

JANUMET XR (sitagliptin/metformin hydrochloride extended release) fixed-dose combination tablets, 100 mg/1000 mg, 50 mg/500 mg, and 50 mg/1000 mg
Company: Merck Sharp & Dohme Corp.
Application No.: 202270
Approval Date: 02/02/2012

Persons with disabilities having problems accessing the PDF files below may call (301) 796-3634 for assistance.


Date created: September 3, 2013

Back to Top    Drugs@FDA

Vision impaired people having problems accessing certain pages of a PDF file may call (301) 796-3634 for assistance.

Note: Documents in PDF format require the Adobe Acrobat Reader®.